Saphris: Does a unique delivery system equal a unique drug?

@article{Gable2011SaphrisDA,
  title={Saphris: Does a unique delivery system equal a unique drug?},
  author={Kelly N. Gable},
  journal={Mental Health Clinician},
  year={2011},
  volume={1},
  pages={133-134}
}
Asenapine was approved by the Food and Drug Administration (FDA) in 2009. This article reviews clinically significant aspects of this new drug including: the FDA-approved indications, mechanism of action, administration, drug interactions, adverse effects, clinical trial evidence, innovative properties and place in therapy.